Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.
Nadia NinosuSusanne MelchersMax KappensteinNina BookenInga HansenMaël BlanchardEmmanuella GuenovaChalid AssafSergij GoerdtJan P NicolayPublished in: Cancers (2023)
Our study presents the combination of mogamulizumab and ECP as an effective therapy in the blood and skin in CTCL with good tolerability, similar to mogamulizumab monotherapy.